Proposed Re-evaluation Decision PRVD2021-04, Cymoxanil and Its Associated End-use Products
This document (Proposed Re-evaluation Decision PRVD2021-04, Cymoxanil and Its Associated End-use Products) presents the proposed re-evaluation decision for the re-evaluation of cymoxanil.
- Publisher - Current Organization Name: Health Canada
- Licence: Open Government Licence - Canada
Data and Resources
-
Proposed Re-evaluation Decision PRVD2021-04, Cymoxanil and Its Associated End-use ProductsHTMLEnglish publication HTML
-
Proposed Re-evaluation Decision PRVD2021-04, Cymoxanil and Its Associated End-use ProductsHTMLFrench publication HTML
Similar records